e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and microbiological aspects of infections in COPD patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects
Amit Agarwal (Pune, India), Baisakhi Ghosh, Amit Agarwal, Akshay Gaike, Shrikant Bhute, Shreyas Kumbhare, Kanchan Pyasi, Bill Brashier, Yogesh Shauche, Sundeep Salvi, Peter Barnes, Louise Donnelly
Source:
International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Session:
Clinical and microbiological aspects of infections in COPD patients
Session type:
Oral Presentation
Number:
1788
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Amit Agarwal (Pune, India), Baisakhi Ghosh, Amit Agarwal, Akshay Gaike, Shrikant Bhute, Shreyas Kumbhare, Kanchan Pyasi, Bill Brashier, Yogesh Shauche, Sundeep Salvi, Peter Barnes, Louise Donnelly. Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects. Eur Respir J 2016; 48: Suppl. 60, 1788
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD
Source: International Congress 2014 – Markers
Year: 2014
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method
Source: Annual Congress 2013 –COPD and infections
Year: 2013
The effect of cigarette smoke on key pathogens in COPD lung infection
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The species-specific inflammatory response of colonising bacteria in stable COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Airway glucose in COPD exacerbations
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept